FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

CADILAHC Share Price Discussion

Cadila Healthcare Ltd.
NSE: CADILAHC | BSE: 532321 | ISIN: INE010B01027 | Sector: Pharmaceuticals and health care
Find answers to all your questions on live CADILAHC message board: Is CADILAHC buy or sell? Should I buy CADILAHC shares? Why are CADILAHC shares falling? Should I invest in CADILAHC stock?

You can also check CADILAHC share price target recommended by brokerages.
@nishantshah91 • Reputation: 1,632

Cadila Healthcare Falls 9% After U.S. FDA Issues Warnings Letter
The Company has taken multiple steps after the inspection to address the observations received from US FDA during the inspection. The Company will continue to take all necessary steps to ensure that the US FDA is fully satisfied with our remediation of the above facility.
Management notes: We are confident of responding to US FDA to address the observations within the statutory time permitted in the letter. This warning letter does not affect the existing business of the Company in the US and the existing product supplies from the Moraiya facility with continue.
View: Hold company has strong compliance mechanism earlier Zydus Cadila has successfully completed USFDA audits of formulations manufacturing facility at Baddi, and AP! manufacturing facilities at Ankleshwar and Dabhasa during the year.
1
reply
Reply
Recent posts in CADILAHC
@researcheducation • Reputation: -63,717

INTRADAY & POSITIONAL
CADILA BUY
ABOVE 272
STOP LOSS 267
TARGETS 276 280 284 ++
Like
reply
Reply
@newsbot • Reputation: 2,570
Cadila, Ipca gain 4-9% after US allows emergency use of antimalarial drugs for COVID-19
Cadila Healthcare and Ipca Labs are prominent manufacturers of hydroxychloroquine and chloroquine in India. Both are antimalarial drugs.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,570
Cadila Healthcare share price rises over 2% on USFDA approval to Zydus for Parkinson's drug
The drug will be manufactured at the group’s manufacturing facility at SEZ, Ahmedabad.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,570
Zydus Cadila gets tentative nod from USFDA for Parkinson's treatment capsule
The approval by the US Food and Drug Administration is for Carbidopa and Levodopa extended-release capsules in the strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and 61.25 mg/245 mg, Cadila Healthcare said in a regulatory filing.
Moneycontrol
Like
reply
Reply
@100billionclub • Reputation: 2,107

BUY CADILAHC ABV 256
Like
reply
Reply (1)
@deep-r16Zfg58I • Reputation: -80
CADILAHC

Type
Buy
Instrument
CADILAHC
Entry Price
₹256
Price@Trade
₹256.5
Target Price
₹290
Stop Price
₹250
Valid Till
Mar 30, 2020 3:20 AM
Margin
₹256 approx for 1 Qty
Status
Validity Over
Exit Price
₹252.3
Net P&L
-1.45% Loss
Like
reply
Reply (2)